In most areas of diabetes research, you don’t hear much until there’s a big breakthrough of some sort. And then it goes dark again.
That’s what happened several years ago on the then-hot topic of xenotransplantation, or the sourcing of islet cells for transplants. Some studies were launched using porcine cells and the press had a field day with headlines like “pig sushi diabetes trial.” Since then? Nada.
But recently, a New Zealand-based company called…
Read more »
For as long as there has been research to cure diabetes, there have been people who believe that a cure will never happen because treating this disease is simply far too profitable. Those who believe in this so-called “conspiracy theory” are convinced that pharma companies have a vested interest in keeping diabetes around as long as possible because peddling their treatments is far bigger business than a cure could ever be.
We all know that…
Read more »
Happy Saturday! Welcome to Ask D’Mine, our weekly advice column hosted by veteran type 1, diabetes author and community educator Wil Dubois. This week, Wil offers some thoughts on burning questions about people with diabetes (PWDs) being able to take to the skies as pilots, and whether losing weight is a “cure” for those with type 2. There might even be a Frank Sinatra reference in there…
{Got your own questions? Email us at AskDMine@diabetesmine.com}
Amit…
Read more »
We were familiar with the company ViaCyte through its former identity as NovoCell, when we reported that they’d managed to successfully control diabetes in mice using embryonic stem cells back in 2008.
Last year, they changed their name, but their two-part mission remained the same: first, to create fully functioning beta cells (the specific kind of islet cells that make insulin and amylin) from embryonic stem cells, and then to find a way to combat…
Read more »
